• 1904 Citations
  • 20 h-Index
19972018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Loretta Gammaitoni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles
Cytokine-Induced Killer Cells Medicine & Life Sciences
Fetal Blood Medicine & Life Sciences
Blood Cells Medicine & Life Sciences
Thrombopoietin Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
SCID Mice Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Stem Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2018

  • 1904 Citations
  • 20 h-Index
  • 58 Article
  • 1 Review article
4 Citations (Scopus)

BRAF and MEK inhibitors increase PD-1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti–PD-1 antibody

Sanlorenzo, M., Vujic, I., Floris, A., Novelli, M., Gammaitoni, L., Giraudo, L., Macagno, M., Leuci, V., Rotolo, R., Donini, C., Basirico, M., Quaglino, P., Fierro, M. T., Giordano, S., Sibilia, M., Carnevale-Schianca, F., Aglietta, M. & Sangiolo, D., Jul 15 2018, In : Clinical Cancer Research. 24, 14, p. 3377-3385 9 p.

Research output: Contribution to journalArticle

Mitogen-Activated Protein Kinase Kinases
Melanoma
Lymphocytes
Antibodies
Recurrence
1 Citation (Scopus)

BRAF-inhibitors can exert control of disease in BRAF T599I mutated melanoma: a case report

Gallo, S., Coha, V., Caravelli, D., Becco, P., Venesio, T., Zaccagna, A., Giacone, E., Marenco, F., Pisacane, A., Racca, M., Gammaitoni, L., Aglietta, M. & Carnevale-Schianca, F., Apr 1 2018, In : Melanoma Research. 28, 2, p. 143-146 4 p.

Research output: Contribution to journalArticle

Melanoma
Mutation
Codon
Valine
Therapeutics
4 Citations (Scopus)

CD44v6 as innovative sarcoma target for CAR-redirected CIK cells

Leuci, V., Casucci, G. M., Grignani, G., Rotolo, R., Rossotti, U., Vigna, E., Gammaitoni, L., Mesiano, G., Fiorino, E., Donini, C., Pisacane, A., ambrosio, L. D., Pignochino, Y., Aglietta, M., Bondanza, A. & Sangiolo, D., May 4 2018, In : OncoImmunology. 7, 5, e1423167.

Research output: Contribution to journalArticle

Cytokine-Induced Killer Cells
Antigen Receptors
Sarcoma
Heterografts
Neoplasms
4 Citations (Scopus)

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.

Mesiano, G., Grignani, G., Fiorino, E., Leuci, V., Rotolo, R., D’Ambrosio, L., Salfi, C., Gammaitoni, L., Giraudo, L., Pisacane, A., Butera, S., Pignochino, Y., Basiricó, M., Capozzi, F., Sapino, A., Aglietta, M. & Sangiolo, D., Nov 2 2018, In : OncoImmunology. 7, 11, e1465161.

Research output: Contribution to journalArticle

Cytokine-Induced Killer Cells
Neoplastic Stem Cells
Sarcoma
Drug Therapy
Molecular Targeted Therapy

Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR

Peraldo-Neia, C., Cavalloni, G., Fenocchio, E., Cagnazzo, C., Gammaitoni, L., Cereda, S., Nasti, G., Satolli, M. A., Aprile, G., Reni, M., Avallone, A., Spadi, R., Venesio, T., Martin, V., Doglioni, C., Frattini, M., Aglietta, M. & Leone, F., 2018, In : PLoS One. 13, 1, p. e0191593

Research output: Contribution to journalArticle

Biliary Tract Neoplasms
oxaliplatin
Chemotherapy
gemcitabine
Protein-Tyrosine Kinases